The Discovery and Characterization of ML218: A Novel, Centrally Active T-Type Calcium Channel Inhibitor with Robust Effects in STN Neurons and in a Rodent Model of Parkinson's Disease.
Xiang Z, Thompson AD, Brogan JT, Schulte ML, Melancon BJ, Mi D, Lewis LM, Zou B, Yang L, Morrison R, Santomango T, Byers F, Brewer K, Aldrich JS, Yu H, Dawson ES, Li M, McManus O, Jones CK, Daniels JS, Hopkins CR, Xie XS, Conn PJ, Weaver CD, Lindsley CW.
Xiang Z, et al. Among authors: dawson es.
ACS Chem Neurosci. 2011 Dec 21;2(12):730-742. doi: 10.1021/cn200090z.
ACS Chem Neurosci. 2011.
PMID: 22368764
Free PMC article.